These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 17403981)

  • 1. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Eliez S; Thompson T; Hinard C; Penniman L; Feinstein C; Kwon H; Jin S; Jo B; Antonarakis SE; Morris MA; Reiss AL
    Nat Neurosci; 2005 Nov; 8(11):1500-2. PubMed ID: 16234808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Hoeft F; Ueno T; Sugiura L; Lee AD; Thompson P; Reiss AL
    J Psychiatr Res; 2011 Mar; 45(3):322-31. PubMed ID: 20817203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
    Gothelf D; Schaer M; Eliez S
    Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
    Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
    J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
    Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: Neuropsychological and behavioral implications.
    Debbané M; Glaser B; David MK; Feinstein C; Eliez S
    Schizophr Res; 2006 Jun; 84(2-3):187-93. PubMed ID: 16545541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
    Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
    Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
    Bearden CE; Jawad AF; Lynch DR; Sokol S; Kanes SJ; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Am J Psychiatry; 2004 Sep; 161(9):1700-2. PubMed ID: 15337663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
    Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome.
    van Amelsvoort T; Zinkstok J; Figee M; Daly E; Morris R; Owen MJ; Murphy KC; De Haan L; Linszen DH; Glaser B; Murphy DG
    Psychol Med; 2008 Jan; 38(1):89-100. PubMed ID: 17493297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
    Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome.
    Glaser B; Debbane M; Hinard C; Morris MA; Dahoun SP; Antonarakis SE; Eliez S
    Am J Psychiatry; 2006 Mar; 163(3):537-9. PubMed ID: 16513880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological profile and neuroimaging in patients with 22Q11.2 Deletion Syndrome: a review.
    Zinkstok J; van Amelsvoort T
    Child Neuropsychol; 2005 Feb; 11(1):21-37. PubMed ID: 15823981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.